Academic Commons

Articles

Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain

Felsky, Daniel; Patrick, Ellis; Schneider, Julie A.; Mostafavi, Sara; Gaiteri, Chris; Patsopoulos, Nikolaos; Bennett, David A.; De Jager, Philip Lawrence

Background
The role of the innate immune system in Alzheimer’s disease (AD) and neurodegenerative disease susceptibility has recently been highlighted in genetic studies. However, we do not know whether risk for inflammatory disease predisposes unaffected individuals to late-life cognitive deficits or AD-related neuropathology. We investigated whether genetic risk scores for seven immune diseases and central nervous system traits were related to cognitive decline (nmax = 1601), classical AD neuropathology (nmax = 985), or microglial density (nmax = 184).


Methods
Longitudinal cognitive decline, postmortem amyloid and tau neuropathology, microglial density, and gene module expression from bulk brain tissue were all measured in participants from two large cohorts (the Rush Religious Orders Study and Memory and Aging Project; ROS/MAP) of elderly subjects (mean age at entry 78 +/− 8.7 years). We analyzed data primarily using robust regression methods. Neuropathologists were blind to clinical data.


Results
The AD genetic risk scores, including and excluding APOE effects, were strongly associated with cognitive decline in all domains (min Puncor = 3.2 × 10− 29). Multiple sclerosis (MS), Parkinson’s disease, and schizophrenia risk did not influence cognitive decline in older age, but the rheumatoid arthritis (RA) risk score alone was significantly associated with microglial density after correction (t146 = − 3.88, Puncor = 1.6 × 10− 4). Post-hoc tests found significant effects of the RA genetic risk score in multiple regions and stages of microglial activation (min Puncor = 1.5 × 10− 6). However, these associations were driven by only one or two variants, rather than cumulative polygenicity. Further, individual MS (Pone-sided < 8.4 × 10− 4) and RA (Pone-sided = 3 × 10− 4) variants associated with higher microglial density were also associated with increased expression of brain immune gene modules.


Conclusions
Our results demonstrate that global risk of inflammatory disease does not strongly influence aging-related cognitive decline but that susceptibility variants that influence peripheral immune function also alter microglial density and immune gene expression in the aging brain, opening a new perspective on the control of microglial and immune responses within the central nervous system. Further study on the molecular mechanisms of peripheral immune disease risk influencing glial cell activation will be required to identify key regulators of these pathways.

Files

  • thumnail for 13024_2018_Article_272.pdf 13024_2018_Article_272.pdf application/pdf 3.51 MB Download File

Also Published In

Title
Molecular Neurodegeneration
DOI
https://doi.org/10.1186/s13024-018-0272-6

More About This Work

Academic Units
Neurology
Published Here
October 1, 2018

Notes

Genomics, Alzheimer’s disease, Microglia, Inflammation, Polygenic score, Innate immunity, Postmortem, Neuropathology, RNA sequencing

Academic Commons provides global access to research and scholarship produced at Columbia University, Barnard College, Teachers College, Union Theological Seminary and Jewish Theological Seminary. Academic Commons is managed by the Columbia University Libraries.